Top Midday Decliners

MT Newswires Live07-10 02:16

Aimei Health Technology (AFJK) terminated its merger deal with United Hydrogen Group, effective immediately, as the companies failed to complete the transaction within the agreed timeframe, according to a statement Wednesday.

Shares of Aimei sank 49% as intraday trading volume jumped to over 165,000 from a daily average of about 10,000.

AstraZeneca (AZN) and its partner Ionis Pharmaceuticals (IONS) said Thursday that a phase 3 trial for eplontersen in people with transthyretin-mediated amyloid cardiomyopathy failed to meet the primary efficacy endpoint.

Shares of Ionis sank 24% as intraday trading volume soared to about 14.5 million from a daily average of roughly 1.89 million.

Rackspace Technology (RXT) said Thursday that it expects a wider Q2 adjusted loss from a year earlier and also lowered its full-year 2026 outlook.

Shares plunged 29% as intraday trading volume surged to over 40.0 million from the stock's daily average of about 24.1 million.

Price: 13.45, Change: -13.24, Percent Change: -49.61

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2650979566?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-10 02:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2650979566","market":"fut","top_or_hot":-1,"title":"Top Midday Decliners","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/AFJK\">Aimei Health</a> Technology (AFJK) terminated its merger deal with United Hydrogen Group, effective immediately, as the companies failed to complete the transaction within the agreed timeframe, according to a statement Wednesday.</p><p>Shares of Aimei sank 49% as intraday trading volume jumped to over 165,000 from a daily average of about 10,000.</p><p>AstraZeneca (AZN) and its partner Ionis Pharmaceuticals (IONS) said Thursday that a phase 3 trial for eplontersen in people with transthyretin-mediated amyloid cardiomyopathy failed to meet the primary efficacy endpoint.</p><p>Shares of Ionis sank 24% as intraday trading volume soared to about 14.5 million from a daily average of roughly 1.89 million.</p><p><a href=\"https://laohu8.com/S/RXT\">Rackspace Technology</a> (RXT) said Thursday that it expects a wider Q2 adjusted loss from a year earlier and also lowered its full-year 2026 outlook.</p><p>Shares plunged 29% as intraday trading volume surged to over 40.0 million from the stock's daily average of about 24.1 million.</p><p>Price: 13.45, Change: -13.24, Percent Change: -49.61</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Decliners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Decliners\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-07-10 02:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/AFJK\">Aimei Health</a> Technology (AFJK) terminated its merger deal with United Hydrogen Group, effective immediately, as the companies failed to complete the transaction within the agreed timeframe, according to a statement Wednesday.</p><p>Shares of Aimei sank 49% as intraday trading volume jumped to over 165,000 from a daily average of about 10,000.</p><p>AstraZeneca (AZN) and its partner Ionis Pharmaceuticals (IONS) said Thursday that a phase 3 trial for eplontersen in people with transthyretin-mediated amyloid cardiomyopathy failed to meet the primary efficacy endpoint.</p><p>Shares of Ionis sank 24% as intraday trading volume soared to about 14.5 million from a daily average of roughly 1.89 million.</p><p><a href=\"https://laohu8.com/S/RXT\">Rackspace Technology</a> (RXT) said Thursday that it expects a wider Q2 adjusted loss from a year earlier and also lowered its full-year 2026 outlook.</p><p>Shares plunged 29% as intraday trading volume surged to over 40.0 million from the stock's daily average of about 24.1 million.</p><p>Price: 13.45, Change: -13.24, Percent Change: -49.61</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2456880835.USD","symbol_name":"ALLIANZ GLOBAL INCOME \"AT\" (USD) ACC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2650979566","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2650979566","pubTimestamp":1783621017,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Aimei Health Technology  terminated its merger deal with United Hydrogen Group, effective immediately, as the companies failed to complete the transaction within the agreed timeframe, according to a statement Wednesday.Shares of Aimei sank 49% as intraday trading volume jumped to over 165,000 from a daily average of about 10,000.AstraZeneca  and its partner Ionis Pharmaceuticals  said Thursday that a phase 3 trial for eplontersen in people with transthyretin-mediated amyloid cardiomyopathy failed to meet the primary efficacy endpoint.Shares of Ionis sank 24% as intraday trading volume soared to about 14.5 million from a daily average of roughly 1.89 million.Rackspace Technology  said Thursday that it expects a wider Q2 adjusted loss from a year earlier and also lowered its full-year 2026 outlook.Shares plunged 29% as intraday trading volume surged to over 40.0 million from the stock's daily average of about 24.1 million.Price: 13.45, Change: -13.24, Percent Change: -49.61","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2456880835.USD":"ALLIANZ GLOBAL INCOME \"AT\" (USD) ACC","AZN":"阿斯利康","LU0708994859.HKD":"TEMPLETON GLOBAL \"A\" (HKD) ACC","BK4007":"制药","IE00B3T34201.USD":"BNY MELLON GLOBAL EQUITY INCOME \"B\" (USD) INC","LU2462157665.USD":"ALLIANZ GLOBAL INCOME \"A\" (USD) INC","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","LU0029864427.USD":"TEMPLETON GLOBAL \"A\" (USD) INC","AFJK":"Aimei Health Technology Co Ltd","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","LU2417539215.USD":"ALLIANZ GLOBAL INCOME \"AMF\" (USD) INC","AZNH":"ASTRAZENECA PLC ADRhedged","LU0128525929.USD":"TEMPLETON GLOBAL \"A\" (USD) ACC","BK4116":"互联网服务与基础架构","BK4585":"ETF&股票定投概念","BK4139":"生物科技","LU0058720904.USD":"联博国际健康护理基金A","LU2237443382.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA USD","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","IONS":"Ionis Pharmaceuticals, Inc","LU2237443549.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA SGD-H","RXT":"Rackspace Technology","LU2237443895.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) ACC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU2237443465.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) INC","LU2237443622.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc USD","LU2236285917.USD":"ALLIANZ GLOBAL INCOME \"AMG\" (USD) INC","LU1267930573.SGD":"TEMPLETON GLOBAL \"AA\" (SGD) ACC A","LU1829250122.USD":"高盛欧洲核心股票组合Acc","LU0310800379.SGD":"FTIF - Templeton Global A Acc SGD","LU2237443978.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc SGD-H","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","BK4608":"AI应用概念股","BK4568":"美国抗疫概念","LU0432979614.USD":"JPM GLOBAL HEALTHCARE \"A\" ACC","BK4588":"碎股"},"translate_title":"午盘跌幅最大","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IONS":1,"RXT":1,"AZNH":0.6,"AFJK":1,"AZN":1},"content_text":"Aimei Health Technology (AFJK) terminated its merger deal with United Hydrogen Group, effective immediately, as the companies failed to complete the transaction within the agreed timeframe, according to a statement Wednesday.Shares of Aimei sank 49% as intraday trading volume jumped to over 165,000 from a daily average of about 10,000.AstraZeneca (AZN) and its partner Ionis Pharmaceuticals (IONS) said Thursday that a phase 3 trial for eplontersen in people with transthyretin-mediated amyloid cardiomyopathy failed to meet the primary efficacy endpoint.Shares of Ionis sank 24% as intraday trading volume soared to about 14.5 million from a daily average of roughly 1.89 million.Rackspace Technology (RXT) said Thursday that it expects a wider Q2 adjusted loss from a year earlier and also lowered its full-year 2026 outlook.Shares plunged 29% as intraday trading volume surged to over 40.0 million from the stock's daily average of about 24.1 million.Price: 13.45, Change: -13.24, Percent Change: -49.61","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2650979566","isCrawlerRequest":true}